Poseida Therapeutics, Inc. Quarterly Interest Expense in USD from Q2 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Poseida Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2019 to Q3 2024.
  • Poseida Therapeutics, Inc. Interest Expense for the quarter ending September 30, 2024 was $2.3M, a 2.64% increase year-over-year.
  • Poseida Therapeutics, Inc. Interest Expense for the twelve months ending September 30, 2024 was $9.07M, a 20.9% decline year-over-year.
  • Poseida Therapeutics, Inc. annual Interest Expense for 2023 was $8.67M, a 36.1% increase from 2022.
  • Poseida Therapeutics, Inc. annual Interest Expense for 2022 was $6.37M, a 89.7% increase from 2021.
  • Poseida Therapeutics, Inc. annual Interest Expense for 2021 was $3.36M, a 4.22% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $9.07M $2.3M +$59K +2.64% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $9.01M $2.26M +$118K +5.51% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $8.9M $2.25M +$225K +11.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $8.67M $2.27M -$2.8M -55.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 $11.5M $2.24M +$461K +26% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $11M $2.14M +$3.68M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 $7.32M $2.03M +$951K +88.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $6.37M $5.06M +$4.22M +503% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 $2.15M $1.78M +$938K +112% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $1.21M -$1.54M -$2.39M -283% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $3.6M $1.08M +$239K +28.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $3.36M $840K -$12K -1.41% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 $3.37M $837K -$11K -1.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $3.38M $843K -$49K -5.49% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $3.43M $838K -$76K -8.32% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $3.51M $852K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 $848K -$87K -9.31% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $892K -$11K -1.22% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $914K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q3 2019 $935K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $903K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.